美国东部时间 10 月 19 日， Ginkgo Bioworks 宣布已经完成了对 Zymergen 的收购。 这意味着原本预计将在明年第一季度完成的、堪称合成生物学领域最为重磅的收购交易提前落定。

(资料图片)

▲ 图｜Ginkgo Bioworks 和 Zymergen（来源：公司官网）

据公布的消息称， Ginkgo Bioworks 将借助此次收购来整合 Zymergen 强大的自动化和软件能力以及其在多种生物工程方法上的丰富经验，以此进一步强化 Ginkgo Bioworks 自有的合成生物学平台。具体而言，Zymergen 的核心自动化和软件技术将整合进 Ginkgo Bioworks 的“Foundry”（铸造厂）中，而生物数据资产将拓展到 “Codebase”（代码库）中。

▲ 图｜Ginkgo Bioworks 公司官网宣布收购消息（来源：公司官网）

据了解， 这是 Ginkgo Bioworks 迄今为止最大规模的一笔收购交易。 “今天，我们完成对 Zymergen 的收购，这标志着我们在未来长期增长的目标中已经迈出了非常重要一步。与此同时，我们也非常高兴 Zymergen 团队加入到 Ginkgo Bioworks ，并把他们的能力整合到我们的合成生物学平台中，这次收购将为 Zymergen 目前正在开发的各种产品概念探索新的合作伙伴关系和机会。”Ginkgo Bioworks 的联合创始人兼首席执行官 Jason Kelly 说道。

早在今年 7 月， Ginkgo Bioworks 和 Zymergen 宣布双方已经达成最终协议： Ginkgo Bioworks 将以全股票交易方式收购 Zymergen，收购预计将于 2023 年第一季度完成。

据收购协议条款， Zymergen 股东以每股 Zymergen 普通股获得 0.9179 股 Ginkgo A 类普通股，收购完成后 Zymergen 股票将不再在纳斯达克交易，Ginkgo A 类普通股将继续在纽约证券交易所交易，而 Zymergen 股东将拥有合并后公司 5.25% 的股份。

一直以来， Ginkgo Bioworks 和 Zymergen 堪称是引领合成生物平台发展的双巨头，两者均是 平台型技术公司 ，双方各自依托数据、软件和自动化构建起专有的合成生物学研发平台。

▲ 图｜Zymergen 融资情况（来源：CB Insights）

Zymergen 成立于 2013 年，总部位于加利福尼亚州埃默里维尔，截至目前，该公司 融资总金额达 8.74 亿美元。 去年 4 月，Zymergen 以每股 31 美元的价格上市，然而在上市 4 个月后，随着核心产品遭遇危机，Zymergen股价应声下跌，其联合创始人 Josh Hoffman 同时卸任首席执行官。

今年 1 月初， Zymergen 宣布，利用其专有的合成生物学平台和大规模宏基因组学数据库开拓一项新的药物发现业务，其初始管线将 专注于高价值肿瘤目标的精准药物。 彼时， Ginkgo Bioworks 则表示将支持 Zymergen 为其先进材料和药物发现业务评估战略替代方案的计划。

▲ 图｜Ginkgo Bioworks 收购情况（来源：CB Insights）

Ginkgo Bioworks 成立于 2008 年，总部位于马萨诸塞州波士顿。该公司旨在开发一个更容易设计细胞的平台，其创立初期专注于香水、杀虫剂等广泛领域，如今随着公司筹集更多资金，它开始进一步探索其合成生物平台在制药领域的使用，并将 Moderna 和 罗氏 列为合作伙伴。

除了此次收购 Zymergen ， Ginkgo Bioworks 自创立以来已经收购了包括 Circularis 、 Bitome 、 FGen 、 Novogy 等在内的多家合成生物技术公司。近期，Ginkgo Bioworks 的拓疆之路更是“动作频频”。

10 月 11 日， Ginkgo Bioworks 与 默沙东 宣布达成合作，其设计开发的工程酶将用作默沙东活性药物成分制造工作中的生物催化剂。据合作条款，默沙东将向 Ginkgo Bioworks 支付一笔未披露的前期研发费用，Ginkgo Bioworks 也有资格获得各种里程碑付款，包括研发和商业，商业里程碑付款总计可能达到 1.44 亿美元。

10 月 18 日， Ginkgo Bioworks 宣布已经完成与全球化工制药巨头 拜耳 的合作交易，同时双方建立了为期 3 年的战略合作伙伴关系，以加快农业生物产品的研发。据悉，此次交易主要分为两个部分，其一，以 8300 万美元收购拜耳旗下西萨克拉门托农业生物制剂研发基地；其二，进一步整合双方先前的合资企业 Joyn Bio 的研发平台资产，通过这两步，Ginkgo Bioworks 将完成对于旗下农业平台的拓展与整合。

合作伙伴关系和机会。”Ginkgo Bioworks 的联合创始人兼首席执行官 Jason Kelly 说道。"}}},"align":"","folded":false}},"GS28dAi04oK0iyxAxBpcRehOnqd":{"id":"GS28dAi04oK0iyxAxBpcRehOnqd","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"Lggyd0mIwo6kccxMN2EcwQKxn1b":{"id":"Lggyd0mIwo6kccxMN2EcwQKxn1b","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":2,"numToAttrib":{"0":["author","6977180476830121987"],"1":["bold","true"]}},"initialAttributedTexts":{"attribs":{"0":"*0+1d*0*1+1l"},"text":{"0":"早在今年 7 月，Ginkgo Bioworks 和 Zymergen 宣布双方已经达成最终协议：Ginkgo Bioworks 将以全股票交易方式收购 Zymergen，收购预计将于 2023 年第一季度完成。"}}},"align":"","folded":false}},"PsOCdOe6cowiscxwWJOcgGFxntb":{"id":"PsOCdOe6cowiscxwWJOcgGFxntb","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"L8ykdycyeoiWM6xSSo0cJhGqnMb":{"id":"L8ykdycyeoiWM6xSSo0cJhGqnMb","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":1,"numToAttrib":{"0":["author","6977180476830121987"]}},"initialAttributedTexts":{"attribs":{"0":"*0+44"},"text":{"0":"据收购协议条款，Zymergen 股东以每股 Zymergen 普通股获得 0.9179 股 Ginkgo A 类普通股，收购完成后 Zymergen 股票将不再在纳斯达克交易，Ginkgo A 类普通股将继续在纽约证券交易所交易，而 Zymergen 股东将拥有合并后公司 5.25% 的股份。"}}},"align":"","folded":false}},"JAYQdkgG0oOU4YxaaWmcGVlUnFf":{"id":"JAYQdkgG0oOU4YxaaWmcGVlUnFf","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"N8SydkIcaoW6KMx4QQTcvoqsnsb":{"id":"N8SydkIcaoW6KMx4QQTcvoqsnsb","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":3,"numToAttrib":{"0":["author","6977180476830121987"],"1":["textHighlightBackground","rgba(255,246,122,0.8)"],"2":["bold","true"]}},"initialAttributedTexts":{"attribs":{"0":"*0+5*0*1+f*0+3*0*1+8*0+n*0*2+7*0+w"},"text":{"0":"一直以来，Ginkgo Bioworks 和 Zymergen 堪称是引领合成生物平台发展的双巨头，两者均是平台型技术公司，双方各自依托数据、软件和自动化构建起专有的合成生物学研发平台。"}}},"align":"","folded":false}},"BS6idaCC0oEqK6xcbGicQjTBn9d":{"id":"BS6idaCC0oEqK6xcbGicQjTBn9d","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"L2sSdySYwoEwi8x2nHScUmYXnJf":{"id":"L2sSdySYwoEwi8x2nHScUmYXnJf","snapshot":{"type":"image","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","align":"center","image":{"token":"boxcno9L8cdyF91oSmTmiwag9Ff","mimeType":"image/png","size":73773,"scale":1,"width":1274,"height":643,"name":"360截图20221020143340450.png"}}},"BaaGdgsCMo4quqxY9wDcGpwnngc":{"id":"BaaGdgsCMo4quqxY9wDcGpwnngc","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":1,"numToAttrib":{"0":["author","6977180476830121987"]}},"initialAttributedTexts":{"attribs":{"0":"*0+v"},"text":{"0":"图｜Zymergen 融资情况（来源：CB Insights）"}}},"align":"center","folded":false}},"Sg8adi4mioGKmQxK3i6cbknZnyf":{"id":"Sg8adi4mioGKmQxK3i6cbknZnyf","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"TcYGdCeySoumimxo34ActZIcntg":{"id":"TcYGdCeySoumimxo34ActZIcntg","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":4,"numToAttrib":{"0":["textHighlightBackground","rgba(255,246,122,0.8)"],"1":["author","6977180476830121987"],"2":["bold","true"],"3":["abbreviation-data","{"id":"ad5f1702-a75d-4baf-ad13-fb86690fdc20","abbr_ids":"enterprise_7064483429781487620","is_visible":1,"is_first":1}"]}},"initialAttributedTexts":{"attribs":{"0":"*1*0+8*1+10*1*2+f*1+25*1*0+c*1+5*3*1+5*1+1"},"text":{"0":"Zymergen 成立于 2013 年，总部位于加利福尼亚州埃默里维尔，截至目前，该公司融资总金额达 8.74 亿美元。去年 4 月，Zymergen 以每股 31 美元的价格上市，然而在上市 4 个月后，随着核心产品遭遇危机，Zymergen股价应声下跌，其联合创始人 Josh Hoffman 同时卸任首席执行官。"}}},"align":"","folded":false}},"R28Ed8aw2oWYEIxs6fQcdvxenSx":{"id":"R28Ed8aw2oWYEIxs6fQcdvxenSx","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"VamIdQwQOoqMMOxYxnDc84pknSg":{"id":"VamIdQwQOoqMMOxYxnDc84pknSg","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":2,"numToAttrib":{"0":["author","6977180476830121987"],"1":["bold","true"]}},"initialAttributedTexts":{"attribs":{"0":"*0+1s*0*1+f*0+1p"},"text":{"0":"今年 1 月初，Zymergen 宣布，利用其专有的合成生物学平台和大规模宏基因组学数据库开拓一项新的药物发现业务，其初始管线将专注于高价值肿瘤目标的精准药物。彼时，Ginkgo Bioworks 则表示将支持 Zymergen 为其先进材料和药物发现业务评估战略替代方案的计划。"}}},"align":"","folded":false}},"QSw4dKCqKoco6mxQ9ICc5nrunAd":{"id":"QSw4dKCqKoco6mxQ9ICc5nrunAd","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"HaSad6IiaoSgMAx2JIXcmSR4n3g":{"id":"HaSad6IiaoSgMAx2JIXcmSR4n3g","snapshot":{"type":"image","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","align":"center","image":{"token":"boxcnFQAOp0JtIusXkENXvnvzje","mimeType":"image/png","size":71661,"scale":1,"width":1247,"height":652,"name":"360截图20221020143500314.png"}}},"CIQkdSICSoGYmexkzZUcjmXAnnc":{"id":"CIQkdSICSoGYmexkzZUcjmXAnnc","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":1,"numToAttrib":{"0":["author","6977180476830121987"]}},"initialAttributedTexts":{"attribs":{"0":"*0+12"},"text":{"0":"图｜Ginkgo Bioworks 收购情况（来源：CB Insights）"}}},"align":"center","folded":false}},"OIM6dY42Kos4u8xgZCqcz6Vdnmf":{"id":"OIM6dY42Kos4u8xgZCqcz6Vdnmf","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"PAIAdMMWsocCEuxQPa3cR4JrnOh":{"id":"PAIAdMMWsocCEuxQPa3cR4JrnOh","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":2,"numToAttrib":{"0":["textHighlightBackground","rgba(255,246,122,0.8)"],"1":["author","6977180476830121987"]}},"initialAttributedTexts":{"attribs":{"0":"*1*0+f*1+2x*1*0+7*1+2*1*0+2*1+7"},"text":{"0":"Ginkgo Bioworks 成立于 2008 年，总部位于马萨诸塞州波士顿。该公司旨在开发一个更容易设计细胞的平台，其创立初期专注于香水、杀虫剂等广泛领域，如今随着公司筹集更多资金，它开始进一步探索其合成生物平台在制药领域的使用，并将 Moderna 和罗氏列为合作伙伴。"}}},"align":"","folded":false}},"Ma2sdwSAkoeM8qxQVTnc5JYjnQe":{"id":"Ma2sdwSAkoeM8qxQVTnc5JYjnQe","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"VQaydUEQMoyseYxUXV5ckBQbn1g":{"id":"VQaydUEQMoyseYxUXV5ckBQbn1g","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":2,"numToAttrib":{"0":["author","6977180476830121987"],"1":["textHighlightBackground","rgba(255,246,122,0.8)"]}},"initialAttributedTexts":{"attribs":{"0":"*0+7*0*1+8*0+s*0*1+b*0+1*0*1+6*0+1*0*1+4*0+1*0*1+6*0+1d"},"text":{"0":"除了此次收购 Zymergen，Ginkgo Bioworks自创立以来已经收购了包括 Circularis、Bitome、FGen、Novogy 等在内的多家合成生物技术公司。近期，Ginkgo Bioworks 的拓疆之路更是“动作频频”。"}}},"align":"","folded":false}},"F4gUdUyoyoMEY0xQPSscAA5jnjd":{"id":"F4gUdUyoyoMEY0xQPSscAA5jnjd","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"CGUadm8GSo8g6Gx8DROcICienUf":{"id":"CGUadm8GSo8g6Gx8DROcICienUf","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":2,"numToAttrib":{"0":["author","6977180476830121987"],"1":["textHighlightBackground","rgba(255,246,122,0.8)"]}},"initialAttributedTexts":{"attribs":{"0":"*0+r*0*1+3*0+40"},"text":{"0":"10 月 11 日，Ginkgo Bioworks 与默沙东宣布达成合作，其设计开发的工程酶将用作默沙东活性药物成分制造工作中的生物催化剂。据合作条款，默沙东将向 Ginkgo Bioworks 支付一笔未披露的前期研发费用，Ginkgo Bioworks 也有资格获得各种里程碑付款，包括研发和商业，商业里程碑付款总计可能达到 1.44 亿美元。"}}},"align":"","folded":false}},"XKUCdsUY8oAIcYxsxZvcPZpvnUc":{"id":"XKUCdsUY8oAIcYxsxZvcPZpvnUc","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"apool":{"nextNum":0,"numToAttrib":{}},"initialAttributedTexts":{"attribs":{"0":""},"text":{"0":""}}},"align":"","folded":false}},"M4cOdCuIIoW8sOxSwHqc5G4onrc":{"id":"M4cOdCuIIoW8sOxSwHqc5G4onrc","snapshot":{"type":"text","parent_id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","comments":[],"locked":false,"hidden":false,"author":"6977180476830121987","children":[],"text":{"initialAttributedTexts":{"text":{"0":"10 月 18 日，Ginkgo Bioworks 宣布已经完成与全球化工制药巨头拜耳的合作交易，同时双方建立了为期 3 年的战略合作伙伴关系，以加快农业生物产品的研发。据悉，此次交易主要分为两个部分，其一，以 8300 万美元收购拜耳旗下西萨克拉门托农业生物制剂研发基地；其二，进一步整合双方先前的合资企业 Joyn Bio 的研发平台资产，通过这两步，Ginkgo Bioworks 将完成对于旗下农业平台的拓展与整合。"},"attribs":{"0":"*0+15*0*1+2*0+34*0*1+8*0+1d"}},"apool":{"numToAttrib":{"0":["author","6977180476830121987"],"1":["textHighlightBackground","rgba(255,246,122,0.8)"]},"nextNum":2}},"align":"","folded":false}},"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4":{"id":"Z7dXdgaAVoKOFRxEl4Hcoh5Inw4","snapshot":{"type":"page","parent_id":"","comments":null,"locked":false,"hidden":false,"author":"6977180476830121987","children":["NUi2dq0gWo20kMxEDv7c1Qx8nlh","ZgowdYKYyo8Q8wxCsiYcsAkYnjf","IqC0daMwcoa2AcxkRxOcd9yCnbh","YIWkdIiQqoEoymxqopjcMcb8n8e","JoyQd8uOoo8uQYxk75ucaLXjnxc","G4A6doyqYogwKoxGyAgcEZVxnAe","FaiWdEemooMAM0xgFItcKrBqnle","E6QydiYWqoaucmxEhKtci4YYnBe","Uku8dq6UyoIyGCx6RjDcVsL8nld","SUSode8i8oOyYQxKynBc8XP9nyg","SywSd6sOCoSeuMxmaG9cLeFhnab","MiOedKIycoeu8ax8X3lcaPRanCf","AYEad2k0eoMuECxiwLWc8zxunpc","Mc6kdK6sko0OagxkbeNcoL4knjd","RYi4di4cAowwesxoft2cjQ4qnTg","Zg6idYCEQowCmMxkJBQcVZz8nZc","Ou6udwSmSoggWIx8VaWcJvP9nRe","JMA0dSCqQoIAE6xZDxKcN1msncW","GS28dAi04oK0iyxAxBpcRehOnqd","Lggyd0mIwo6kccxMN2EcwQKxn1b","PsOCdOe6cowiscxwWJOcgGFxntb","L8ykdycyeoiWM6xSSo0cJhGqnMb","JAYQdkgG0oOU4YxaaWmcGVlUnFf","N8SydkIcaoW6KMx4QQTcvoqsnsb","BS6idaCC0oEqK6xcbGicQjTBn9d","L2sSdySYwoEwi8x2nHScUmYXnJf","BaaGdgsCMo4quqxY9wDcGpwnngc","Sg8adi4mioGKmQxK3i6cbknZnyf","TcYGdCeySoumimxo34ActZIcntg","R28Ed8aw2oWYEIxs6fQcdvxenSx","VamIdQwQOoqMMOxYxnDc84pknSg","QSw4dKCqKoco6mxQ9ICc5nrunAd","HaSad6IiaoSgMAx2JIXcmSR4n3g","CIQkdSICSoGYmexkzZUcjmXAnnc","OIM6dY42Kos4u8xgZCqcz6Vdnmf","PAIAdMMWsocCEuxQPa3cR4JrnOh","Ma2sdwSAkoeM8qxQVTnc5JYjnQe","VQaydUEQMoyseYxUXV5ckBQbn1g","F4gUdUyoyoMEY0xQPSscAA5jnjd","CGUadm8GSo8g6Gx8DROcICienUf","XKUCdsUY8oAIcYxsxZvcPZpvnUc","M4cOdCuIIoW8sOxSwHqc5G4onrc","Yci0d4wygouQy4xUX5qcvBtjnDe","Ok6WdCMcAoykQ2xuuzBcOsNQnXd","UyOUdE24Co4C6exQ3PqcEuVtnoe","PW0ydGIQso6a0sx6TCTcKuv6nAe","ZAs6da0A2o4yC4xieKKc1fCTnxe","KcUkdAOWkoi6Iwxo1zecOWNgnnd","Legwd8m0qokwAuxQaqacPW8DnlY","KcAUdYgiio6KwUxiEhacruSwn5e"],"text":{"apool":{"nextNum":1,"numToAttrib":{"0":["author","6977180476830121987"]}},"initialAttributedTexts":{"attribs":{"0":"*0+r"},"text":{"0":"交易提前落定！Ginkgo完成对Zymergen的收购"}}},"align":""}}},"payloadMap":{"E6QydiYWqoaucmxEhKtci4YYnBe":{"level":1},"Uku8dq6UyoIyGCx6RjDcVsL8nld":{"level":1},"SywSd6sOCoSeuMxmaG9cLeFhnab":{"level":1},"MiOedKIycoeu8ax8X3lcaPRanCf":{"level":1},"AYEad2k0eoMuECxiwLWc8zxunpc":{"level":1},"Mc6kdK6sko0OagxkbeNcoL4knjd":{"level":1},"Zg6idYCEQowCmMxkJBQcVZz8nZc":{"level":1},"Ou6udwSmSoggWIx8VaWcJvP9nRe":{"level":1},"JMA0dSCqQoIAE6xZDxKcN1msncW":{"level":1},"GS28dAi04oK0iyxAxBpcRehOnqd":{"level":1},"Lggyd0mIwo6kccxMN2EcwQKxn1b":{"level":1},"PsOCdOe6cowiscxwWJOcgGFxntb":{"level":1},"L8ykdycyeoiWM6xSSo0cJhGqnMb":{"level":1},"JAYQdkgG0oOU4YxaaWmcGVlUnFf":{"level":1},"N8SydkIcaoW6KMx4QQTcvoqsnsb":{"level":1},"BS6idaCC0oEqK6xcbGicQjTBn9d":{"level":1},"BaaGdgsCMo4quqxY9wDcGpwnngc":{"level":1},"Sg8adi4mioGKmQxK3i6cbknZnyf":{"level":1},"TcYGdCeySoumimxo34ActZIcntg":{"level":1},"R28Ed8aw2oWYEIxs6fQcdvxenSx":{"level":1},"VamIdQwQOoqMMOxYxnDc84pknSg":{"level":1},"QSw4dKCqKoco6mxQ9ICc5nrunAd":{"level":1},"CIQkdSICSoGYmexkzZUcjmXAnnc":{"level":1},"OIM6dY42Kos4u8xgZCqcz6Vdnmf":{"level":1},"PAIAdMMWsocCEuxQPa3cR4JrnOh":{"level":1},"Ma2sdwSAkoeM8qxQVTnc5JYjnQe":{"level":1},"VQaydUEQMoyseYxUXV5ckBQbn1g":{"level":1},"F4gUdUyoyoMEY0xQPSscAA5jnjd":{"level":1},"CGUadm8GSo8g6Gx8DROcICienUf":{"level":1},"XKUCdsUY8oAIcYxsxZvcPZpvnUc":{"level":1},"M4cOdCuIIoW8sOxSwHqc5G4onrc":{"level":1}},"extra":{"mention_page_title":{},"external_mention_url":{}},"isKeepQuoteContainer":false,"pasteFlag":"60987cfa-a8a1-4d5e-8b7b-238296c7e214"}" data-lark-record-format="docx/record">

关键词： Zymergen